top of page
Search

Higher buprenorphine doses associated with improved retention in treatment for opioid use disorder


NIH-funded study suggests need to reevaluate opioid addiction treatment recommendations in the era of fentanyl


Individuals with opioid use disorder who were prescribed a lower buprenorphine dose were 20% more likely to discontinue treatment than those on a higher dose, according to a study of patients prescribed buprenorphine in Rhode Island from 2016 to 2020, as fentanyl became widely available. The study, published today in JAMA Network Open, was supported by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, and conducted by researchers at Brown University, Providence, Rhode Island; NIDA and the Rhode Island Department of Health.


コメント


bottom of page